↓ Skip to main content
What is this page? Embed badge

The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment: based on 2-year follow-up HERA trial data

Overview of attention for article published in Breast Cancer Research and Treatment, July 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

policy
2 policy sources

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
46 Mendeley
Summary Policy documents Dimensions citations
So far, Altmetric has seen 3 policy documents that reference this research output.

Mammakarzinom der Frau; Diagnostik, Therapie und Nachsorge: Evidenzbericht: Synopse evidenzbasierter Leitlinien-Empfehlungen zur Diagnostik, Therapie und Nachsorge des Mammakarzinoms

Cited by The Association of the Scientific Medical Societies in Germany on

The Association of the Scientific Medical Societies in Germany (AWMF) is an umbrella organization of over 150 societies, and advises the government of the Federal Republic of Germany as well as the governments of the German federal countries in all topics of scientific medicine and medical research and classification.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.